Optimal testing strategies for incidental anti-mitochondrial M2 antibody-positive patients
Künye
Ergenc, I., Gozaydinoglu, B., Keklikkiran, C., & Yilmaz, Y. (2024). Optimal testing strategies for incidental anti-mitochondrial M2 antibody-positive patients. Hepatology Forum, 5 (3), 165-166. http://doi.org/10.14744/hf.2024.2024.0007Özet
We carefully considered the letter entitled “Optimal testing strategies
for incidental anti-mitochondrial M2 antibody-positive patients.” We
sincerely appreciate the authors’ insights and the thoughtful review
of our paper, “The risk of development of primary biliary cholangitis
among incidental antimitochondrial M2 antibody-positive patients”.[1,2]
We wish to offer clarification on the issues raised in the letter.